Skip to main content
Premium Trial:

Request an Annual Quote

Watchmaker Genomics, Molecular Loop Partner for SARS-CoV-2 Surveillance Assays

NEW YORK – Protein engineering company Watchmaker Genomics and assay developer Molecular Loop have partnered to commercialize genetic tests for pathogen surveillance, the firms said on Thursday.

Boulder, Colorado-based Watchmaker will contribute its expertise in computational biology, high-throughput enzyme engineering, and large-scale enzyme production while Molecular Loop, based in Newton, Massachusetts, will provide molecular inversion probe (MIP)-based assays.

"We believe that our collaboration will result in broader access to a high-performance, customizable assay platform that can support applications in precision medicine, infectious disease, and biomarker discovery," said Trey Foskett, cofounder and CEO of Watchmaker, in a statement.

The MIP assays use redundant probe tiling and a streamlined workflow to eliminate the need for traditional shotgun library preparation, according to the firms, and combine the sensitivity and specificity of hybridization-based target enrichment with the ease and scalability of amplicon-based assays. The technology was initially developed by Good Start Genetics and acquired by Molecular Loop from Invitae in 2018.

Molecular Loop has already launched a SARS-CoV-2 research panel in collaboration with Watchmaker, a sequencing assay that is robust to strain variation.

"Partnering with Watchmaker Genomics allowed us to incorporate customized enzyme formulations and quickly scale up manufacturing to meet the ever-increasing demand from our customers performing critical viral surveillance work," said Eric Boyden, cofounder and head of R&D and innovation at Molecular Loop.

Watchmaker recently also partnered with Twist Bioscience to develop high-throughput sequencing assays for tumor profiling, inherited disease diagnostics, liquid biopsies, and minimal residual disease monitoring.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.